[Federal Register Volume 87, Number 224 (Tuesday, November 22, 2022)]
[Notices]
[Pages 71365-71366]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25403]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Call for 
Nominations

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Call for Nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is soliciting 
nominations for the position of Radiation Oncologist Physician 
(Brachytherapy) on the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI). Nominees should be currently practicing radiation 
oncologists.

DATES: Nominations are due on or before January 23, 2023.
    Nomination Process: Submit an electronic copy of resume or 
curriculum vitae, along with a cover letter, to Dr. Celimar Valentin-
Rodriguez, [email protected]. The cover letter should 
describe the nominee's current duties and responsibilities and express 
the nominee's interest in the position. Please ensure that the resume 
or curriculum vitae includes the following information, if applicable: 
education; certification(s); professional association and committee 
membership activities; duties and responsibilities in current and 
previous clinical, research, and/or academic position(s).

FOR FURTHER INFORMATION CONTACT: Dr. Celimar Valentin-Rodriguez, U.S. 
Nuclear Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards; (301) 415-7124; [email protected].

[[Page 71366]]


SUPPLEMENTARY INFORMATION: ACMUI members possess the medical and 
technical skills needed to address evolving issues. The current 
membership is comprised of the following professionals: (a) nuclear 
medicine physician; (b) nuclear cardiologist; (c) two radiation 
oncologists; (d) diagnostic radiologist; (e) therapy medical physicist; 
(f) nuclear medicine physicist; (g) nuclear pharmacist; (h) health care 
administrator; (i) radiation safety officer; (j) patients' rights 
advocate; (k) Food and Drug Administration representative; and (l) 
Agreement State representative. For additional information about 
membership on the ACMUI, visit the ACMUI Membership web page, http://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html.
    The ACMUI brachytherapy radiation oncologist provides advice on 
issues associated with radiation oncology and the clinical use of 
brachytherapy, including the use of permanently implanted microspheres. 
This advice includes providing input on NRC proposed rules and 
guidance, providing recommendations on the training and experience 
requirements for physicians specializing in this use, identifying 
medical events associated with this use, evaluating non-routine uses of 
byproduct material and emerging medical technologies, bringing key 
issues in the radiation oncology community to the attention of NRC 
staff, and other radiation oncology issues as they relate to radiation 
safety and NRC medical use policy.
    The ACMUI advises the NRC on policy and technical issues that arise 
in the regulation of the medical use of byproduct material. 
Responsibilities of an ACMUI member include providing comments on 
changes to the NRC regulations and guidance; evaluating certain non-
routine uses of byproduct material; providing technical assistance in 
licensing, inspection, and enforcement cases; and bringing key issues 
to the attention of the NRC staff, for appropriate action. Committee 
members currently serve a four-year term and may be considered for 
reappointment to an additional term.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to ACMUI business. Members are expected to attend 
semi-annual meetings at NRC headquarters in Rockville, Maryland and to 
participate in teleconferences or virtual meetings, as needed. Members 
who are not Federal employees at the time of their appointment are 
compensated for their service. In addition, members are reimbursed for 
travel (including per diem in lieu of subsistence) and are reimbursed 
secretarial and correspondence expenses. Full-time Federal employees 
are reimbursed for travel expenses only.
    Security Background CHECK: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 
interest.

    Dated at Rockville, Maryland, this 17th day of November, 2022.

    For the U.S. Nuclear Regulatory Commission.
Brooke P. Clark,
Secretary of the Commission.
[FR Doc. 2022-25403 Filed 11-21-22; 8:45 am]
BILLING CODE 7590-01-P